Published in J Exp Clin Cancer Res on January 22, 2010
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol (2015) 1.91
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal (2011) 1.50
Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation. Asian J Androl (2012) 0.95
Epigenetic susceptibility factors for prostate cancer with aging. Prostate (2013) 0.94
Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast. Histochem Cell Biol (2012) 0.88
Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone. Reprod Biol Endocrinol (2011) 0.86
Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma. ScientificWorldJournal (2012) 0.86
Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res (2013) 0.85
Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects. Theranostics (2016) 0.84
The role of β-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer. J Cancer (2017) 0.75
Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44
PCNA, the maestro of the replication fork. Cell (2007) 10.43
Proteoglycans as modulators of growth factor activities. Cell (1991) 4.45
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell (2005) 3.67
Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res (2005) 2.58
How to decide? Different methods of calculating gene expression from short oligonucleotide array data will give different results. BMC Bioinformatics (2006) 2.13
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer (2006) 2.09
Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest (1998) 1.70
Decorin prevents metastatic spreading of breast cancer. Oncogene (2005) 1.69
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res (2003) 1.67
Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem (2000) 1.55
Translesion synthesis in mammalian cells. Exp Cell Res (2006) 1.44
Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci U S A (1999) 1.39
An antimetastatic role for decorin in breast cancer. Am J Pathol (2008) 1.34
Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (1991) 1.27
A powerful method for detecting differentially expressed genes from GeneChip arrays that does not require replicates. BMC Bioinformatics (2006) 1.03
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer (2005) 1.02
Expression of different proteoglycans in human breast tumors. Biochemistry (Mosc) (2007) 0.99
Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol (2003) 0.93
The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study. Histopathology (2005) 0.88
Identification and characterisation of imprinted genes in the mouse. Brief Funct Genomic Proteomic (2004) 0.84
A composite element binding the vitamin D receptor and the retinoic X receptor alpha mediates the transforming growth factor-beta inhibition of decorin gene expression in articular chondrocytes. J Biol Chem (2001) 0.83
Array2BIO: from microarray expression data to functional annotation of co-regulated genes. BMC Bioinformatics (2006) 0.83
[A murine model of mammary adenocarcinoma (VI TA2MA-891) with high rate of spontaneous metastases in the lungs]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (1994) 0.78
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76
A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65
Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol (2006) 4.81
Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry (2008) 3.16
Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing. Mol Cell (2002) 2.78
Designing a wearable navigation system for image-guided cancer resection surgery. Ann Biomed Eng (2014) 2.33
Cannulation of the innominate artery with a side graft in arch surgery. Ann Thorac Surg (2010) 2.24
Hereditary neuropathy with liability to pressure palsy: an investigation in a rare and large Chinese family. Eur Neurol (2012) 1.99
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer (2008) 1.89
p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol (2005) 1.86
Toward simpler and faster genome-wide mutagenesis in mice. Nat Genet (2007) 1.77
The Tlx gene regulates the timing of neurogenesis in the cortex. J Neurosci (2004) 1.75
Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res (2003) 1.71
A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond. Nat Protoc (2008) 1.69
A single center experience of sorafenib in advanced hepatocellular carcinoma patients: evaluation of prognostic factors. Eur J Gastroenterol Hepatol (2011) 1.63
miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer (2011) 1.60
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer (2008) 1.50
Autoreactive T and B cells induce the development of bronchus-associated lymphoid tissue in the lung. Am J Respir Cell Mol Biol (2013) 1.49
Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res (2011) 1.48
Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res (2010) 1.47
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol (2002) 1.45
Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron (2011) 1.45
Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res (2010) 1.44
The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials. Tumour Biol (2014) 1.43
Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat (2006) 1.40
Increase in visceral fat per se does not induce insulin resistance in the canine model. Obesity (Silver Spring) (2014) 1.40
CTCF/cohesin-mediated DNA looping is required for protocadherin α promoter choice. Proc Natl Acad Sci U S A (2012) 1.39
Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice. J Exp Clin Cancer Res (2011) 1.38
Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett (2006) 1.34
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol (2014) 1.33
Vasculogenic mimicry: current status and future prospects. Cancer Lett (2007) 1.32
Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J Clin Invest (2004) 1.28
Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol (2004) 1.27
Boron-doped carbon nanotubes as metal-free electrocatalysts for the oxygen reduction reaction. Angew Chem Int Ed Engl (2011) 1.24
Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun (2005) 1.24
Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol (2008) 1.24
Sequence analysis and expression mapping of the rat clustered protocadherin gene repertoires. Neuroscience (2006) 1.23
Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep (2006) 1.22
Vapor-solid growth and characterization of aluminum nitride nanocones. J Am Chem Soc (2005) 1.20
Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20
Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer (2012) 1.20
Associations between access to farmers' markets and supermarkets, shopping patterns, fruit and vegetable consumption and health indicators among women of reproductive age in eastern North Carolina, U.S.A. Public Health Nutr (2013) 1.17
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer (2011) 1.17
Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications. Cell Cycle (2012) 1.16
A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo. Genes Dev (2013) 1.13
Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab (2013) 1.12
Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol (2008) 1.11
NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res (2011) 1.10
Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev (2012) 1.10
Protocadherin clusters and cell adhesion kinase regulate dendrite complexity through Rho GTPase. J Mol Cell Biol (2012) 1.09
Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci U S A (2013) 1.09
MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis. BMC Cancer (2010) 1.09
Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow. Stem Cells Dev (2005) 1.08
The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells. Int J Nanomedicine (2009) 1.08
The association between the food environment and weight status among eastern North Carolina youth. Public Health Nutr (2011) 1.07
A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis. J Exp Clin Cancer Res (2010) 1.06
Generation and erasure of femtosecond laser-induced periodic surface structures on nanoparticle-covered silicon by a single laser pulse. Opt Lett (2014) 1.06
Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility. J Med Chem (2013) 1.06
Primary visual cortex volume and total neuron number are reduced in schizophrenia. J Comp Neurol (2007) 1.05
Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma. J Exp Clin Cancer Res (2008) 1.04
Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models. Cancer Sci (2007) 1.04
Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res (2010) 1.04
Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin Cancer Res (2008) 1.03
BLIMP1 regulates cell growth through repression of p53 transcription. Proc Natl Acad Sci U S A (2007) 1.03
MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochim Biophys Sin (Shanghai) (2012) 1.02
Role of complement activation in obliterative bronchiolitis post-lung transplantation. J Immunol (2013) 1.01
Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity. Proc Natl Acad Sci U S A (2011) 1.01
Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci (2012) 1.01
A novel mutation in the MIP gene is associated with autosomal dominant congenital nuclear cataract in a Chinese family. Mol Vis (2011) 1.01
Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 18 cases, with emphasis on early diagnosis and appropriate treatment strategies. Hum Pathol (2011) 1.01
p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat Cell Biol (2007) 1.01
Molecular dynamics study on the correlation between structure and sensitivity for defective RDX crystals and their PBXs. J Mol Model (2012) 1.01
BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer (2007) 1.01
Microcirculation patterns in different stages of melanoma growth. Oncol Rep (2006) 1.01
Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res (2009) 1.00
Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol (2013) 0.99
Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging (2012) 0.99
Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer. Mol Cancer (2014) 0.99
B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells. BMC Cancer (2014) 0.99
Probing the electronic structure and property of neutral and charged arsenic clusters (As(n)(+1,0,-1), n≤8) using Gaussian-3 theory. J Phys Chem A (2011) 0.99
Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicol In Vitro (2008) 0.99
Evaluating subconjunctival bleb function after trabeculectomy using slit-lamp optical coherence tomography and ultrasound biomicroscopy. Chin Med J (Engl) (2008) 0.99
Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs. Proc Natl Acad Sci U S A (2012) 0.98